NEOGENOMICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Neogenomics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Neogenomics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$17.7M, a 4.41% increase year-over-year.
  • Neogenomics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$77.7M, a 19.3% increase year-over-year.
  • Neogenomics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$88M, a 39% increase from 2022.
  • Neogenomics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$144M, a 1628% decline from 2021.
  • Neogenomics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$8.35M, a 300% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$77.7M -$17.7M +$817K +4.41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$78.5M -$18.6M +$5.69M +23.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-05
Q1 2024 -$84.2M -$27.1M +$3.73M +12.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-05
Q4 2023 -$88M -$14.3M +$8.36M +36.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$96.3M -$18.5M +$18.3M +49.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$115M -$24.3M +$11M +31.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-05
Q1 2023 -$126M -$30.8M +$18.6M +37.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-05
Q4 2022 -$144M -$22.7M +$19.1M +45.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$163M -$36.9M -$16.5M -81.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$147M -$35.3M -$111M -147% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$35.6M -$49.4M -$27.3M -123% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$8.35M -$41.8M -$57.2M -371% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $48.8M -$20.3M -$22.9M -896% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $71.7M $75.9M +$82.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$11M -$22.1M -$15.1M -217% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 $4.17M $15.4M +$9.12M +145% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$4.95M $2.56M +$414K +19.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$5.36M -$6.82M -$8.82M -443% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 $3.45M -$6.98M -$4.55M -188% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 $8.01M $6.3M +$5.94M +1684% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 $2.06M $2.14M +$120K +5.93% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.94M $1.99M +$2.37M Apr 1, 2019 Jun 30, 2019 10-Q 2020-10-29
Q1 2019 -$428K -$2.42M -$3.07M -476% Jan 1, 2019 Mar 31, 2019 10-Q 2020-10-29
Q4 2018 $2.64M $353K -$4.2M -92.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $6.84M $2.02M +$6.29M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 $549K -$380K -$863K -179% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 $1.41M $644K +$1.81M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$397K $4.55M +$10.8M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$11.2M -$4.26M -$4.2M -6264% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$6.97M $483K +$70K +16.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$7.04M -$1.17M -$1.32M -852% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$5.72M -$6.22M -$4.75M -323% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$972K -$67K +$58K +46.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$1.03M $413K +$589K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$1.62M $155K +$916K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$2.54M -$1.47M -$2.52M -241% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$15K -$125K +$166K +57% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$181K -$176K -$450K -164% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 $269K -$761K -$863K -846% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 $1.13M $1.05M +$190K +22.2% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-04-18
Q3 2014 $942K -$291K -$1.19M -132% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-04-18
Q2 2014 $2.13M $274K +$1K +0.37% Apr 1, 2014 Jun 30, 2014 10-K/A 2016-04-18
Q1 2014 $2.13M $102K +$99K +3300% Jan 1, 2014 Mar 31, 2014 10-K/A 2016-04-18
Q4 2013 $2.03M $857K +$971K Oct 1, 2013 Dec 31, 2013 10-K 2014-02-24
Q3 2013 $1.06M $900K +$1.88M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$813K $273K -$278K -50.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 -$535K $3K -$600K -99.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $65K -$114K -$266K -175% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-24
Q3 2012 $331K -$975K -$832K -582% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-24
Q2 2012 $1.16M $551K +$844K Apr 1, 2012 Jun 30, 2012 10-K 2014-02-24
Q1 2012 $319K $603K +$1.5M Jan 1, 2012 Mar 31, 2012 10-K 2014-02-24
Q4 2011 -$1.18M $152K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 -$143K +$1.06M +88.1% Jul 1, 2011 Sep 30, 2011 10-K 2014-02-24
Q2 2011 -$293K +$685K +70% Apr 1, 2011 Jun 30, 2011 10-K 2014-02-24
Q1 2011 -$893K Jan 1, 2011 Mar 31, 2011 10-K 2014-02-24
Q3 2010 -$1.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-25
Q2 2010 -$978K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.